clinic
microbiolog
evolv
respons
clinic
fig
mani
advanc
area
past
decad
exampl
autom
system
detect
identif
microorgan
identif
resist
organ
includ
autom
bloodcultur
assay
system
phenotyp
identif
bacteria
antibioticsensit
test
computer
interpret
system
also
develop
led
signific
chang
microbiolog
rather
enabl
sampl
process
fewer
personnel
provid
increas
intra
interlaboratori
reproduc
similar
develop
seen
immunoassay
enzymelink
immunosorb
assay
elisa
extens
autom
standard
recent
year
also
becom
cheaper
mani
autom
test
avail
initi
design
mass
test
blood
destin
blood
bank
later
innov
led
western
blot
confirm
hiv
infect
lyme
diseas
develop
test
rapid
detect
antihiv
antibodi
saliva
worldwid
mainli
cost
contain
measur
infecti
diseas
gener
tendenc
past
year
central
clinic
microbiolog
laboratori
serv
sever
hospit
therefor
maxim
effici
test
lowest
howev
central
clinic
microbiolog
laboratori
result
lack
consult
physician
clinic
scientist
also
rapid
develop
genet
detect
identif
microbi
pathogen
period
mainli
nucleicacid
amplif
polymeras
chain
reaction
pcr
pcr
use
univers
primer
follow
sequenc
amplif
product
enabl
rapid
identif
cultur
uncultur
bacteria
fungi
procedur
avail
mani
larg
univers
hospit
laboratori
also
carri
new
compani
privat
sector
genet
test
also
use
identifi
dna
sequenc
associ
antimicrobi
resist
viral
load
also
determin
pcr
found
use
method
evalu
antivir
therapi
final
molecular
method
allow
type
microorgan
help
analys
epidemiolog
outbreak
identifi
sourc
well
distinguish
relaps
reinfect
case
persist
microorgan
inde
infect
control
consid
part
clinic
microbiolog
futur
new
technolog
chang
avail
skill
personnel
prevail
econom
environ
influenc
clinic
use
molecularbiolog
techniqu
dramat
chang
clinic
microbiolog
integr
two
disciplin
import
challeng
futur
addit
detect
wellknown
pathogen
laboratori
futur
also
abl
recogn
new
pathogen
particip
foodsafeti
monitor
bioterror
recent
experi
shown
necess
laboratori
abl
rapidli
develop
diagnost
test
new
diseas
high
social
impact
case
outbreak
sever
acut
respiratori
syndrom
sar
mean
must
also
avail
rapid
transfer
technolog
laboratori
routin
diagnost
carri
current
problem
scientif
respons
emerg
threat
far
rapid
administr
respons
often
prolong
delay
approv
new
diagnost
test
use
outsid
research
laboratori
articl
discuss
latest
techniqu
avail
clinic
microbiologist
fig
appli
specul
futur
might
hold
clinic
microbiolog
laboratori
current
technolog
clinic
microbiolog
sequencebas
identif
microorgan
avail
highthroughput
thermal
cycler
new
dna
polymeras
autom
sequenc
togeth
reduct
cost
reagent
led
sequencebas
identif
microorgan
becom
use
reliabl
altern
phenotyp
method
identif
moreov
patent
taq
polymeras
expir
march
decreas
cost
pcr
sequenc
develop
molecular
microbiolog
therefor
progress
clinic
microbiolog
link
develop
onlin
databas
scientist
worldwid
send
sequenc
databas
explos
amount
sequenc
data
avail
databas
avail
present
largest
versatil
septemb
genbank
contain
dna
sequenc
includ
complet
genom
archaea
bacteria
eukaryot
virus
strict
criteria
must
use
interpret
sequenc
data
major
drawback
onlin
databas
depend
qualiti
sequenc
submit
scientist
inaccur
report
sequenc
lead
individu
microorgan
misidentifi
even
whole
group
organ
requir
reclassif
moreov
avail
current
data
could
potenti
becom
compromis
futur
common
intern
repositori
would
use
bacteria
studi
univers
gene
ribosom
rna
gene
enabl
correct
classif
numer
microorgan
includ
previous
unfortun
possibl
discrimin
speci
compar
rrna
gene
sequenc
present
know
gene
present
bacteri
sequenc
gene
exampl
rpob
encod
rna
polymeras
sigmafactor
differ
bacteri
speci
therefor
use
bacteri
identif
larg
databas
sequenc
gene
avail
eukaryot
rrna
gene
also
use
univers
gene
increas
number
rrna
sequenc
contrast
common
gene
detect
virus
although
pcr
target
develop
viru
famili
univers
gene
use
higher
level
identif
requir
strain
type
investig
diseas
outbreak
antibiot
resist
nosocomi
infect
suspect
bioterror
attack
differ
gene
sequenc
enabl
differ
level
identif
depend
gene
use
genu
speci
subspeci
even
strain
organ
establish
crucial
determin
whether
one
clinic
isol
strain
comparison
sever
genom
sequenc
might
requir
studi
identifi
highli
variabl
genom
fragment
led
develop
sever
techniqu
includ
multilocu
sequenc
similar
identif
tool
also
develop
sequencebas
type
techniqu
use
intergen
noncod
spacer
like
variabl
one
wide
use
intergen
spacer
intern
transcrib
spacer
specif
fulli
autom
bioinformat
tool
bibi
bioinformat
bacteri
identif
identifi
microorgan
combin
sequenc
databas
phylogenydisplay
programm
quantit
pcr
develop
molecular
beacon
fluoresc
probe
probe
produc
roch
molecular
system
inc
made
realtim
monitor
pcr
amplif
quantif
nucleic
acid
clinic
specimen
beacon
hairpinshap
oligonucleotid
probe
fluorophor
emit
photon
close
associ
quencher
absorb
photon
presenc
complementari
strand
dna
hairpin
structur
unfold
fluoresc
emit
measur
determin
amount
dna
present
multipl
target
use
fluorophor
differ
emiss
spectra
technolog
highli
sensit
commerci
avail
appli
biosystem
perkinelm
corp
lightcycl
roch
diagnost
corp
system
advantag
realtim
pcr
rapid
assay
min
abil
quantifi
identifi
pcr
product
directli
without
use
agaros
gel
fact
contamin
nucleic
acid
limit
kit
avail
detect
quantif
dna
rna
clinic
sampl
techniqu
specif
develop
enabl
followup
patient
hiv
hepat
c
infect
amplitech
ame
bioscienc
bayer
diagnost
roch
diagnost
dna
microarray
develop
microarray
analysi
mileston
sever
area
microbiolog
clinic
microbiolog
microarray
use
microorgan
detect
identif
geneexpress
analysi
microarray
consist
mani
probe
discret
locat
solid
substrat
glass
probe
pcr
product
oligonucleotid
target
pcr
product
genom
dna
total
rna
amplifi
rna
arna
complementari
dna
plasmid
dna
bacteri
suspens
clinic
pcr
use
detect
dna
clinic
specimen
microarray
use
identifi
amplifi
product
hybrid
array
compos
pathogenspecif
probe
use
broadrang
primer
amplifi
rrna
gene
singl
pcr
use
detect
multipl
pathogen
simultan
dna
microarray
use
detect
bacteria
number
possibl
hybrid
high
sequenc
pcr
product
array
possibl
dna
microarray
also
use
strain
identif
genotyp
array
incorpor
speciesspecif
gene
sequenc
reactiv
profil
isol
refer
strain
antigen
microarray
serolog
assay
abil
detect
specif
antibodi
sever
pathogen
simultan
wide
applic
diagnosi
infecti
indirect
immunofluoresc
assay
ifa
commonli
use
detect
antibodi
infecti
easi
use
sensit
specif
recent
protein
array
use
develop
compar
fluoresc
assay
measur
concentr
specif
protein
antibodi
complex
lack
stabil
fluoresc
dye
longer
problem
use
newgener
alexa
dye
molecular
probe
avail
sever
emiss
colour
allow
multipl
stain
spot
specif
fluoresc
detect
confoc
scan
microscopi
quantifi
use
intern
calibr
curv
dye
enabl
develop
prototyp
antigen
microarray
detect
antibodi
human
sera
specif
one
sever
pathogen
antigen
microarray
lyme
diseas
similarli
microarray
specif
antigen
toxoplasma
gondii
cytomegaloviru
herpesviru
rubella
viru
gave
favour
result
use
detect
reactiv
immunoglobulin
pioneer
studi
provid
evid
antigenmicroarray
analysi
could
becom
import
diagnost
tool
techniqu
enabl
ifa
standard
interoper
interlaboratori
variat
minim
also
possibl
digit
ifa
photograph
enabl
store
exchang
easili
mass
spectrometri
mass
spectrometri
analyt
techniqu
use
detect
minut
quantiti
molecul
complex
refin
instrument
facilit
use
mass
spectrometri
clinic
microbiolog
laboratori
use
sequenc
pcr
amplif
product
instead
sanger
method
use
present
molecular
identif
bacteria
base
sequenc
univers
rrna
twoday
task
includ
cultur
time
perform
use
pure
cultur
bacteria
massspectrometri
analysi
basespecif
fragment
pattern
pcramplifi
dna
recent
studi
techniqu
rapid
identif
bacteri
isol
detect
specif
rrna
gene
fragment
amplifi
complex
environment
studi
base
pair
determin
techniqu
show
promis
becom
standard
method
identif
pathogen
strain
type
determin
mutat
associ
resist
bacteria
virus
mass
spectrometri
also
import
develop
proteom
use
identifi
increasingli
quantifi
larg
number
protein
complex
sampl
particular
form
proteinchip
array
technolog
combin
timeofflight
mass
spectrometri
call
surfaceenhanc
laserdesorptionion
timeofflight
mass
spectrometri
selditofm
allow
determin
complex
protein
pattern
serum
bodi
fluid
tissu
techniqu
offer
advantag
speed
simplic
sensit
condit
hard
diagnos
alzheim
autoimmun
use
diagnosi
infecti
diseas
experiment
data
publish
far
microscopi
microscopi
techniqu
evolv
respect
three
factor
natur
signal
userfriendli
equip
digit
computer
process
imag
electron
microscop
complic
instrument
use
research
simplifi
increasingli
use
clinic
microbiolog
laboratori
use
rapid
screen
routin
clinic
sampl
stool
sampl
also
detect
virus
tissu
cultur
neg
stain
viral
pathogen
identifi
within
minut
arriv
clinic
tissuecultur
specimen
electronmicroscopi
electron
microscopi
use
rapidli
identifi
bacillu
anthraci
recent
anthrax
letter
attack
unit
also
identifi
genu
coronaviru
sar
viru
implement
new
technolog
autom
pattern
remot
oper
microscop
telemicroscopi
use
digit
imag
acquisit
review
imag
increas
use
electron
microscopi
flow
cytometri
flow
cytometri
fcm
origin
develop
autom
method
measur
optic
fluoresc
characterist
cell
particl
use
earli
second
world
war
unit
state
armi
detect
bacteria
spore
flow
cytomet
userfriendli
less
expens
becom
increasingli
import
clinic
almost
microorgan
detect
directli
clinic
specimen
fcm
bacteria
detect
particl
liquid
sampl
case
bacteraemia
bacteriuria
also
identifi
use
polyclon
monoclon
antibodi
coat
fluoresc
molecul
fcm
appli
success
detect
wide
rang
bacteria
patient
specimen
includ
blood
urin
exud
effus
bile
bronchiallavag
fluid
even
flow
cytomet
design
specif
urin
analysi
avail
commerci
simultan
determin
concentr
bacteria
red
white
blood
cell
squamou
cell
exampl
flow
cytomet
manufactur
sysmex
corp
eukaryot
fcm
studi
mostli
use
candida
spp
giardia
lamblia
small
size
virus
detect
directli
use
fcm
detect
indirectli
infect
cell
clinic
sampl
inocul
cultur
virus
cell
cultur
fcm
detect
quantifi
viral
antigen
surfac
within
infect
cell
fcm
also
detect
quantifi
viral
nucleic
acid
situ
hybrid
specif
viral
nucleic
acid
cell
suspens
simultan
identifi
infect
cell
cell
phenotyp
applic
fcm
use
sever
virus
includ
hiv
serolog
studi
antigenco
microspher
incub
sera
fluorescenceconjug
antibodi
human
igg
ad
second
step
fcm
use
detect
fluoresc
fcm
also
simultan
detect
antibodi
one
antigen
coat
differ
antigen
differents
particl
fcm
even
analys
antibodi
respons
hiv
simultan
detect
specif
antibodi
variou
antigen
viru
given
versatil
fcm
like
number
applic
techniqu
clinic
microbiolog
increas
futur
growth
microorgan
could
evalu
fluorogenicsubstratehydrolysi
could
also
use
similarli
develop
portabl
flow
cytomet
could
use
detect
act
biowarfar
new
techniqu
adapt
detect
microorgan
clinic
specimen
one
main
challeng
clinic
microbiolog
identif
microorgan
clinic
specimen
achiev
use
follow
method
growth
microorgan
cultur
use
media
cell
line
vari
incub
time
temperatur
atmospher
experi
shown
hypothesi
microorgan
grown
laboratori
might
necessarili
ii
detect
microorgan
within
infect
tissu
light
electron
microscopi
iii
detect
identif
previous
unknown
dna
rna
fragment
antigen
appropri
test
depend
incid
infect
contagi
agent
health
consequ
patient
commun
cellcultur
system
made
crucial
contribut
diagnosi
infecti
diseas
caus
virus
intracellular
bacteria
system
made
direct
isol
identif
microorgan
possibl
also
enabl
product
antigen
serolog
assay
evalu
efficaci
antimicrobi
agent
product
singl
cellcultur
system
far
found
suitabl
isol
intracellular
microorgan
search
suscept
cell
line
continu
anoth
sourc
progress
develop
cultur
media
analysi
genom
sequenc
avail
sequenc
allow
import
metabol
pathway
miss
identifi
could
therefor
permit
design
cultur
media
specif
particular
spectacular
advanc
diagnosi
infecti
diseas
recent
introduct
molecular
detect
method
especi
pcr
rtpcr
pcr
revers
transcript
rna
molecular
techniqu
also
enabl
detect
multipl
infecti
agent
includ
bacteria
virus
fungi
multiplex
microarray
detect
potenti
agent
quantit
assay
realtim
avail
complet
genom
sequenc
computer
databas
facilit
ration
select
pcr
sequenc
primer
primer
specif
test
use
silico
tool
blast
basic
local
align
search
tool
repeat
sequenc
select
increas
sensit
anoth
advantag
facil
select
new
specif
set
primer
contamin
encount
pcr
assay
exampl
suicid
major
pitfal
molecular
detect
microorgan
number
falseposit
result
due
contamin
homemad
pcr
problem
overcom
fulli
autom
process
process
sampl
sequenc
molecular
identif
current
limit
presenc
clinic
sampl
inhibitor
remov
complet
boil
ad
bovin
serum
case
virus
discoveri
hepat
c
viru
trigger
use
molecular
method
search
unknown
viral
agent
clinic
rais
suggest
mani
human
diseas
unknown
aetiolog
might
caus
unrecogn
virus
hepat
c
e
virus
identifi
immunoscreen
differenti
hybrid
librari
construct
without
human
tt
viru
character
use
represent
differ
method
might
use
detect
unknown
virus
includ
dnase
treatment
serum
follow
sequenceindepend
singleprim
amplif
sispa
detect
antibodi
serum
easi
obtain
store
send
filter
paper
indirect
diagnosi
infecti
diseas
detect
specif
antibodi
continu
key
approach
clinic
microbiologist
individu
readytous
assay
would
avail
doctor
surgeri
platform
test
highthroughput
screen
diagnosi
could
develop
atdoctor
serolog
test
would
use
rapid
determin
statu
patient
speedi
decisionmak
regard
postexposur
prophylaxi
treatment
addit
rapid
detect
specif
igm
epidem
could
help
improv
isol
measur
patient
suspect
infect
antigen
microarray
enabl
test
sever
pathogen
parallel
use
littl
serum
reagent
pathogen
known
caus
agent
particular
clinic
syndrom
could
therefor
test
simultan
use
antigen
microarray
moreov
versatil
new
assay
allow
emerg
pathogen
quickli
incorpor
test
futur
develop
antigen
microarray
technolog
includ
develop
autom
indirect
diagnosi
infecti
diseas
microarray
apparatu
could
fulli
autom
result
output
gener
output
would
rapid
overal
process
probabl
take
less
hour
autom
microarray
could
test
sever
paramet
simultan
exampl
test
antigen
differ
class
antibodi
thu
allow
pathologydriven
test
instead
pathogendriven
test
carri
present
sever
antigen
test
simultan
develop
lead
severalfold
decreas
labour
time
consequ
reduct
cost
autom
microarray
suitabl
mass
screen
sera
epidemiolog
studi
blood
bank
diagnost
carri
singl
serum
sampl
clinic
microbiolog
laboratori
antimicrobialsuscept
test
two
strategi
avail
determin
antimicrobi
suscept
phenotyp
genom
method
phenotyp
method
bacteria
includ
dilut
discdiffus
method
realtim
pcr
use
fastidi
bacteria
grown
tissu
fcm
prove
use
studi
physiolog
effect
antimicrobi
agent
bacteri
cell
also
use
antimicrobialsuscept
test
indic
bactericid
bacteriostat
effect
result
obtain
rapidli
often
less
hour
mix
popul
might
respond
antimicrobi
agent
differ
way
studi
sever
commerci
compani
produc
fcm
kit
enabl
antibioticsuscept
test
carri
rapidli
clinic
microbiolog
laboratori
new
develop
field
fcm
antibioticsuscept
test
includ
assay
slowgrow
bacteria
drug
resist
parasit
although
increasingli
recogn
phenomenon
gener
test
clinic
laboratori
present
lack
standard
method
fcm
use
success
detect
resist
antimalari
drug
plasmodium
case
virus
fcm
use
screen
understand
activ
antivir
compound
test
suscept
clinic
isol
hiv
detect
gene
mutat
respons
resist
antimicrobi
agent
altern
phenotyp
detect
carri
directli
clinic
specimen
molecular
test
resist
develop
commerci
bacteria
staphylococcu
aureu
staphylococcu
kit
grade
roch
resist
oxacillin
primarili
mediat
meca
also
develop
virus
exampl
trugen
genotyp
kit
bayer
detect
mutat
gene
encod
hiv
proteas
revers
transcriptas
cytomegaloviru
resist
ganciclovir
mainli
caus
mutat
gene
encod
panel
gene
known
associ
resist
expect
increas
consider
futur
commun
organ
microbi
surveil
report
autom
method
microbi
identif
allow
epidemiolog
trend
follow
easili
hospit
commun
similarli
autom
molecular
diagnosi
resist
key
antibiot
could
allow
bacteri
resist
hospit
survey
onlin
inform
updat
weekli
provid
data
pertin
infectioncontrol
depart
one
exist
also
clinic
physician
exampl
weekli
tabul
document
case
respiratori
synciti
viru
influenza
viru
rotaviru
could
help
establish
prevent
measur
likewis
regular
tabul
microbi
antibiot
resist
trend
assist
hospit
make
empir
recommend
antibiot
treatment
clinic
microbiolog
laboratori
gener
organ
clinic
microbiolog
laboratori
futur
subject
much
tabl
fig
work
carri
laboratori
could
cede
patient
doctor
commerci
develop
selftest
kit
detect
hiv
infect
use
saliva
blood
spot
diagnos
group
streptococcu
throat
infect
number
avail
atdoctor
test
might
increas
could
potenti
includ
detect
group
b
streptococci
vagina
pregnant
women
detect
aureu
nasal
passag
patient
healthcar
worker
test
could
made
avail
outpati
clinic
organ
clinic
microbiolog
laboratori
futur
might
follow
current
trend
life
scienc
develop
larg
central
laboratori
organ
effici
transport
sampl
laboratori
computerbas
commun
result
hospitalbas
laboratori
larg
disappear
unit
state
recent
time
although
result
increas
physician
dissatisfact
clinic
microbiolog
servic
tabl
larg
central
laboratori
howev
abl
meet
increas
demand
specif
test
perform
infrequ
enabl
increas
process
sampl
night
weekend
also
provid
improv
access
highli
special
expert
creation
larg
central
laboratori
requir
train
technician
engin
use
sophist
techniqu
instrument
addit
molecular
identif
microorgan
requir
train
bioinformat
role
differ
type
personnel
clinic
microbiolog
laboratori
futur
might
follow
highli
qualifi
dedic
technician
engin
would
requir
maintain
instrument
platform
owe
increas
complex
diagnost
test
would
perform
technician
new
diagnost
test
would
develop
engin
activ
clinic
microbiologist
would
therefor
reorient
toward
evalu
interpret
test
includ
determin
sensit
specif
predict
valu
commun
result
clinician
particular
infectiousdiseas
specialist
advis
antibiot
therapi
sampl
strategi
conjunct
infectiousdiseas
specialist
follow
trend
diseas
epidemiolog
report
trend
infectioncontrol
depart
coordin
work
technician
engin
overal
strategi
laboratori
implement
new
test
stop
use
other
contribut
intern
scientif
commun
report
case
rare
infecti
diseas
anticip
capac
laboratori
handl
highli
pathogen
microorgan
appropri
level
safeti
increas
futur
certainli
larger
laboratori
creat
would
expect
capac
grow
hazard
microorgan
biosafeti
level
detect
agent
might
use
bioterror
deal
emerg
pathogen
detect
uncultur
virus
electron
microscopi
alreadi
mention
necess
laboratori
advanc
capabl
shown
recent
case
sar
outbreak
anthrax
bioterror
attack
laboratori
could
work
refer
centr
could
connect
nation
intern
network
servic
local
region
area
also
remot
area
includ
develop
countri
sampl
strategi
choic
laboratori
test
sampl
strategi
use
clinic
microbiolog
need
improv
futur
sever
reason
request
laboratori
test
diagnos
infecti
diseas
depend
larg
knowledg
physician
care
patient
result
consider
variabl
appropri
sampl
submit
therefor
accuraci
result
laboratori
diagnos
exampl
standard
sampl
infecti
endocard
three
blood
cultur
serolog
test
requir
diagnosi
could
dramat
reduc
number
cultureneg
endocard
diseas
pneumonia
meningoenceph
number
known
aetiolog
agent
increas
depend
mani
epidemiolog
factor
identif
aetiolog
agent
benefit
use
versatil
diagnost
tool
optim
effici
sampl
strategi
laboratori
test
primarili
evidencebas
optim
diagnost
effici
possibl
strategi
would
sampl
syndrom
exampl
nosocomi
pneumonia
endocard
infecti
arthriti
meningoenceph
uveiti
fever
return
tropic
area
strategi
base
extens
review
intern
literatur
identifi
potenti
aetiolog
given
syndrom
appropri
clinic
sampl
laboratori
test
could
deduc
inform
diagnost
kit
could
develop
syndrom
strategi
would
enabl
ration
search
aetiolog
agent
limit
use
unnecessari
test
improv
costeffect
diagnosi
anoth
advantag
strategi
could
coupl
versatil
diagnost
method
enabl
identif
larg
panel
microorgan
versatil
method
avail
cultur
molecular
detect
broadrang
standard
pcr
assay
fcm
detect
assay
broadrang
microarray
digit
pictur
key
develop
clinic
microbiolog
technolog
avail
produc
digit
pictur
enabl
imag
librari
establish
readili
exchang
includ
pictur
taken
clinic
examin
cutan
sign
present
light
confoc
electronmicroscopi
pictur
imag
microarray
analys
although
still
rare
microbiolog
report
enhanc
digit
imag
organ
involv
inclus
digit
photograph
gramstain
acidfaststain
prepar
technic
possibl
preced
provid
imag
alreadi
set
current
patholog
radiolog
inform
system
pictur
digit
enabl
inform
sent
instantli
email
feasibl
use
staticimag
telepatholog
assess
gramstain
microbiolog
prepar
evalu
posit
although
select
inform
microscop
field
transmiss
prerequisit
major
applic
imag
use
obtain
expert
advic
particular
import
emerg
reemerg
agent
group
b
agent
bioterror
case
microbi
agent
must
confin
secur
laboratori
digit
imag
freeli
exchang
email
digit
pictur
recent
help
manag
patient
suspect
smallpox
anthrax
patient
present
multipl
haemorrhag
vesicl
face
anonym
digit
pictur
clinic
featur
email
unit
state
center
diseas
control
prevent
obtain
expert
use
pictur
emphas
sar
addit
appropri
microbiolog
pictur
email
clinician
incorpor
patient
medic
record
conclus
substanti
chang
role
clinic
microbiolog
laboratori
past
decad
ongo
technolog
revolut
rapidli
transform
research
diagnost
therapeut
tool
howev
still
requir
reliabl
standard
sampl
biolog
test
increas
inform
exchang
intern
futur
organ
clinic
microbiolog
laboratori
probabl
follow
area
life
scienc
larg
central
laboratori
local
head
posit
role
expert
clinic
microbiolog
process
becom
import
question
interpret
diagnost
test
requir
differ
level
expertis
predict
valu
test
depend
intrins
qualiti
preval
diseas
popul
therefor
final
interpret
reli
microbiologist
physician
instanc
indic
clinic
epidemiolog
data
laboratori
make
possibl
diagnosi
made
case
commun
intrins
valu
test
exampl
sensit
specif
might
allow
infectiousdiseas
specialist
make
diagnosi
onsit
fig
final
need
consult
rare
diseas
expert
around
world
use
internet
increas
experi
receiv
queri
diagnosi
treatment
whippl
diseas
q
fever
sever
time
week
queri
assist
probabl
increas
number
expert
particular
field
becom
readili
identifi
physician
even
patient
internet
